• 1
    Fordice J, Kershaw C, El-Naggar A, Goepfert H. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg. 1999; 125: 149-152.
  • 2
    Spiro RH, Koss LG, Hajdu SI, Strong EW. Tumors of minor salivary origin. A clinicopathologic study of 492 cases. Cancer. 1973; 31: 117-129.
  • 3
    Huang M, Ma D, Sun K, Yu G, Guo C, Gao F. Factors influencing survival rate in adenoid cystic carcinoma of the salivary glands. Int J Oral Maxillofac Surg. 1997; 26: 435-439.
  • 4
    Khafif A, Anavi Y, Haviv J, Fienmesser R, Calderon S, Marshak G. Adenoid cystic carcinoma of the salivary glands: a 20-year review with long-term follow-up. Ear Nose Throat J. 2005; 84: 662, 664-667.
  • 5
    Dodd RL, Slevin NJ. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol. 2006; 42: 759-769.
  • 6
    Ciccolallo L, Licitra L, Cantu G, Gatta G; EUROCARE Working Group. Survival from salivary glands adenoid cystic carcinoma in European populations. Oral Oncol. 2009; 45: 669-674.
  • 7
    Spiro RH, Huvos AG, Strong EW. Adenoid cystic carcinoma: factors influencing survival. Am J Surg. 1979; 138: 579-583.
  • 8
    Matsuba HM, Simpson JR, Mauney M, Thawley SE. Adenoid cystic salivary gland carcinoma: a clinicopathologic correlation. Head Neck Surg. 1986; 8: 200-204.
  • 9
    Goepfert H, Luna MA, Lindberg RD, White AK. Malignant salivary gland tumors of the paranasal sinuses and nasal cavity. Arch Otolaryngol. 1983; 109: 662-668.
  • 10
    Perzin KH, Gullane P, Clairmont AC. Adenoid cystic carcinomas arising in salivary glands: a correlation of histologic features and clinical course. Cancer. 1978; 42: 265-282.
  • 11
    Vrielinck LJ, Ostyn F, van Damme B, van den Bogaert W, Fossion E. The significance of perineural spread in adenoid cystic carcinoma of the major and minor salivary glands. Int J Oral Maxillofac Surg. 1988; 17: 190-193.
  • 12
    Ghosal N, Mais K, Shenjere P, et al. Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma. Br J Oral Maxillofac Surg. 2011; 49: 510-515.
  • 13
    Ross PJ, Teoh EM, A'hern RP, et al. Epirubicin, cisplatin and protracted venous infusion 5-fluorouracil chemotherapy for advanced salivary adenoid cystic carcinoma. Clin Oncol (R Coll Radiol). 2009; 21: 311-314.
  • 14
    Wiseman SM, Popat SR, Rigual NR, et al. Adenoid cystic carcinoma of the paranasal sinuses or nasal cavity: a 40-year review of 35 cases. Ear Nose Throat J. 2002; 81: 510-514, 516-517.
  • 15
    Miglianico L, Eschwege F, Marandas P, Wibault P. Cervico-facial adenoid cystic carcinoma: study of 102 cases. Influence of radiation therapy. Int J Radiat Oncol Biol Phys. 1987; 13: 673-678.
  • 16
    Spiro RH. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg. 1997; 174: 495-498.
  • 17
    Belani CP, Eisenberger MA, Gray WC. Preliminary experience with chemotherapy in advanced salivary gland neoplasms. Med Pediatr Oncol. 1988; 16: 197-202.
  • 18
    Licitra L, Cavina R, Grandi C, et al. Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients. Ann Oncol. 1996; 7: 640-642.
  • 19
    Tsukuda M, Kokatsu T, Ito K, Mochimatsu I, Kubota A, Sawaki S. Chemotherapy for recurrent adeno- and adenoidcystic carcinomas in the head and neck. J Cancer Res Clin Oncol. 1993; 119: 756-758.
  • 20
    Le Tourneau C, Razak AR, Levy C, et al. Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland. Br J Ophthalmol. 2011; 95: 1483-1489.
  • 21
    Prokopakis EP, Snyderman CH, Hanna EY, Carrau RL, Johnson JT, D'Amico F. Risk factors for local recurrence of adenoid cystic carcinoma: the role of postoperative radiation therapy. Am J Otolaryngol. 1999; 20: 281-286.
  • 22
    Rosai J. Major and minor salivary gland tumors. In: Rosai J, ed. Rosai and Ackerman's Surgical Pathology. 9th ed. London: Mosby; 2004: 873-917.
  • 23
    Locati LD, Perrone F, Losa M, et al. Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs). Oral Oncol. 2009; 45: 986-990.
  • 24
    Vila L, Liu H, Al-Quran SZ, Coco DP, Dong HJ, Liu C. Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland. Mod Pathol. 2009; 22: 1296-1302.
  • 25
    Surveillance Epidemiology and End Results Program. Glossary of statistical terms. Updated January 28, 2011. Available at: Accessed March 2010.
  • 26
    Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA, eds. SEER Summary Staging Manual 2000: Codes and Coding Instructions. Bethesda, MD: National Cancer Institute; 2001.
  • 27
    Kleinbaum DG, Kupper LL, Muller KE. Applied Regression Analysis and Other Multivariable Methods. 2nd ed. Boston, MA: PWS-Kent; 1988.
  • 28
    Boukheris H, Curtis RE, Land CE, Dores GM. Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2899-2906.
  • 29
    Land CE, Saku T, Hayashi Y, et al. Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation-related risk. Radiat Res. 1996; 146: 28-36.
  • 30
    Abern MR, Dude AM, Coogan CL. Marital status independently predicts testis cancer survival—an analysis of the SEER database. Urol Oncol. [published online ahead of print September 25, 2010.]
  • 31
    Johnson TV, Master VA. Decreased cancer survival in individuals separated at time of diagnosis: critical period for cancer pathophysiology? Cancer. 2010; 116: 5564; author reply 5564.
  • 32
    Wang L, Wilson SE, Steward DB, Hollenbeak CS. Marital status and colon cancer outcomes in US Surveillance, Epidemiology and End Results registries: does marriage affect cancer survival by gender and stage? Cancer Epidemiol. 2011; 35: 417-422.
  • 33
    Lloyd S, Yu JB, Wilson LD, Decker RH. Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol. 2011; 34: 76-81.